Cameron J McKinzie

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Pseudomonas Aeruginosa

Systemic Sclerosis

Cystic Fibrosis

Top Venues

Pediatric pulmonology

This page only lists publications with an associated author ORCID identifier.

Publications

Nidhi Patel, Maria Ansar, Anh Pham, Kelly Thomsen, Cameron J McKinzie, Deepika Polineni, Charles R Esther, Rebekah F Brown
Gilbert's syndrome leads to elevated bilirubin after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis. Pediatric pulmonology 59 (4) (2024)
Cameron J McKinzie, Charissa W Kam, Morgan C Jones, Laura B Gifford, Ceila E Loughlin, Terry L Noah, Vivek K Shenoy, Elisabeth P Dellon
Elevated creatine phosphokinase and rhabdomyolysis associated with elexacaftor/tezacaftor/ivacaftor use in cystic fibrosis. Pediatric pulmonology 59 (6) (2024)
Nidhi Patel, Maria Ansar, Anh Pham, Kelly Thomsen, Cameron J McKinzie, Deepika Polineni, Charles R Esther, Rebekah F Brown
Gilbert's syndrome leads to elevated bilirubin after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis. Pediatric pulmonology (2024)
Cameron J McKinzie, Charissa W Kam, Morgan C Jones, Laura B Gifford, Ceila E Loughlin, Terry L Noah, Vivek K Shenoy, Elisabeth P Dellon
Elevated creatine phosphokinase and rhabdomyolysis associated with elexacaftor/tezacaftor/ivacaftor use in cystic fibrosis. Pediatric pulmonology 59 (6) (2024)
Richard De Vuyst, Charissa W Kam, Cameron J McKinzie, Charles R Esther
Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor. Pediatric pulmonology (2024)
Cameron J McKinzie, Stephanie R Duehlmeyer, Charissa W Kam, Julie Safirstein
Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy. Pediatric pulmonology (2024)
Richard De Vuyst, Charissa W Kam, Cameron J McKinzie, Charles R Esther
Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor. Pediatric pulmonology 59 (7) (2024)
Cameron J McKinzie, Charissa W Kam, Morgan C Jones, Laura B Gifford, Ceila E Loughlin, Terry L Noah, Vivek K Shenoy, Elisabeth P Dellon
Elevated creatine phosphokinase and rhabdomyolysis associated with elexacaftor/tezacaftor/ivacaftor use in cystic fibrosis. Pediatric pulmonology (2024)
Richard De Vuyst, Charissa W Kam, Cameron J McKinzie, Charles R Esther
Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor. Pediatric pulmonology 59 (7) (2024)
Nidhi Patel, Maria Ansar, Anh Pham, Kelly Thomsen, Cameron J McKinzie, Deepika Polineni, Charles R Esther, Rebekah F Brown
Gilbert's syndrome leads to elevated bilirubin after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis. Pediatric pulmonology 59 (4) (2024)
Richard C De Vuyst, Erin Bennard, Charissa W Kam, Cameron J McKinzie, Charles R Esther
Elexacaftor/tezacaftor/ivacaftor treatment reduces airway inflammation in cystic fibrosis. Pediatric pulmonology (2023)
Richard C De Vuyst, Erin Bennard, Charissa W Kam, Cameron J McKinzie, Charles R Esther
Elexacaftor/tezacaftor/ivacaftor Treatment Reduces Airway Inflammation in Cystic Fibrosis. Pediatric pulmonology (2023)
Cameron J McKinzie, William A Gower, James S Hagood, Timothy J Vece
Use of pirfenidone in pediatric patients with interstitial lung disease and pulmonary fibrosis. Pediatric pulmonology (2023)
Cameron J McKinzie, Charissa W Kam, Jeffrey T Zobell, David C Young
Effective pharmacy provider handoff communication for transition of patient care in CF. Pediatric pulmonology (2023)
Timothy J Vece, William A Gower, Stephanie D Davis, Ashley Austin, Cameron J McKinzie, Joseph E Hatch, Miriam Davis, James S Hagood
Building a pediatric rare lung disease program: It takes a community of villages. Pediatric pulmonology 57 (11) (2022)
Cameron J McKinzie, James S Hagood, Elizabeth K Fiorino, Martha P Fishman, Rebekah J Nevel, William A Gower, Timothy J Vece
The role of pharmacy services beyond cystic fibrosis: A case for support in childhood interstitial lung disease. Pediatric pulmonology 57 (6) (2022)
Cameron J McKinzie, Charissa W Kam, Rachel Parry, Marcus Darby, Casey R Tak
Pharmacist-administered audiology screening for pediatric cystic fibrosis patients exposed to high-dose aminoglycosides: A pilot study. Pediatric pulmonology 57 (7) (2022)
Thomas W Laudone, Lauren Garner, Charissa W Kam, Charles R Esther, Cameron J McKinzie
Novel therapies for treatment of resistant and refractory nontuberculous mycobacterial infections in patients with cystic fibrosis. Pediatric pulmonology (2021)
Cameron J McKinzie, Lori Chen, Kim Ehlert, Alison G Grisso, Alaina Linafelter, Lisa Lubsch, Catherine E O'Brien, Alice C Pan, Brittany A Bruch, E Claire Elson
Off-label use of intravenous antimicrobials for inhalation in patients with cystic fibrosis. Pediatric pulmonology (2020)
Cameron J McKinzie, Charles R Esther, Timothy J Vece
Continuous vancomycin in a pediatric cystic fibrosis patient. Pediatric pulmonology 53 (1) (2017)